D Van Eyck

1.8k total citations
33 papers, 1.4k citations indexed

About

D Van Eyck is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, D Van Eyck has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 21 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Physiology. Recurrent topics in D Van Eyck's work include Schizophrenia research and treatment (25 papers), Diet and metabolism studies (13 papers) and Diabetes Treatment and Management (10 papers). D Van Eyck is often cited by papers focused on Schizophrenia research and treatment (25 papers), Diet and metabolism studies (13 papers) and Diabetes Treatment and Management (10 papers). D Van Eyck collaborates with scholars based in Belgium, Netherlands and Croatia. D Van Eyck's co-authors include Marc D. Binder, Ruud van Winkel, Martien Wampers, André Scheen, Joseph Peuskens, Linda Hanssens, J. Peuskens, L. Hanssens, A Scheen and Kim Sweers and has published in prestigious journals such as Schizophrenia Bulletin, Schizophrenia Research and The Journal of Clinical Psychiatry.

In The Last Decade

D Van Eyck

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Van Eyck Belgium 16 1.1k 663 371 146 110 33 1.4k
Paul Mackin United Kingdom 17 637 0.6× 248 0.4× 141 0.4× 53 0.4× 150 1.4× 34 1.1k
K.G. Kahl Germany 4 514 0.5× 190 0.3× 214 0.6× 110 0.8× 171 1.6× 8 836
Claudia Asenjo‐Lobos Chile 10 820 0.8× 165 0.2× 181 0.5× 60 0.4× 57 0.5× 24 1.3k
Tara B. Daley United States 9 547 0.5× 240 0.4× 320 0.9× 32 0.2× 46 0.4× 9 759
D. Gustafson United States 9 470 0.4× 105 0.2× 656 1.8× 68 0.5× 145 1.3× 12 1.3k
Calum D. Moulton United Kingdom 14 149 0.1× 386 0.6× 177 0.5× 271 1.9× 158 1.4× 36 1.1k
Anne M. Frederickson United States 10 687 0.6× 218 0.3× 90 0.2× 36 0.2× 73 0.7× 11 837
Anette Riisgaard Ribe Denmark 16 313 0.3× 87 0.1× 123 0.3× 274 1.9× 128 1.2× 22 908
Candy W. Y. Law Canada 8 282 0.3× 144 0.2× 162 0.4× 47 0.3× 85 0.8× 9 640
Aisha A. Seyal United States 8 109 0.1× 378 0.6× 408 1.1× 397 2.7× 165 1.5× 8 1.1k

Countries citing papers authored by D Van Eyck

Since Specialization
Citations

This map shows the geographic impact of D Van Eyck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Van Eyck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Van Eyck more than expected).

Fields of papers citing papers by D Van Eyck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Van Eyck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Van Eyck. The network helps show where D Van Eyck may publish in the future.

Co-authorship network of co-authors of D Van Eyck

This figure shows the co-authorship network connecting the top 25 collaborators of D Van Eyck. A scholar is included among the top collaborators of D Van Eyck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Van Eyck. D Van Eyck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Binder, Marc D., et al.. (2010). Physical health management in psychiatric settings. European Psychiatry. 25(S2). S22–S28. 47 indexed citations
2.
Binder, Marc D., Kim Sweers, D Van Eyck, et al.. (2008). Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review. Schizophrenia Research. 101(1-3). 295–303. 198 indexed citations
3.
Winkel, Ruud van, Marc D. Binder, D Van Eyck, et al.. (2008). Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disorders. 10(2). 342–348. 157 indexed citations
4.
Wampers, Martien, Marc D. Binder, Ruud van Winkel, et al.. (2007). Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: Evaluation of incidence and screening. Schizophrenia Bulletin. 33(2). 507–507. 1 indexed citations
5.
Scheen, A J, Marc D. Binder, L. Hanssens, et al.. (2007). P353 - Anomalies de la tolérance au glucose chez les patients schizophrènes traités par antipsychotiques de seconde génération : étude comparative prospective de 3 mois. The World Journal of Biological Psychiatry. 2 indexed citations
6.
Binder, Marc D., L. Hanssens, Martien Wampers, et al.. (2007). Prevalence and incidence rates of metabolic abnormalities and diabetes in a prospective study of patients treated with second-generation antipsychotics. Schizophrenia Bulletin. 33(2). 560–560. 14 indexed citations
7.
Binder, Marc D., Ruud van Winkel, D Van Eyck, et al.. (2006). Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study.. Clinical Practice and Epidemiology in Mental Health. 2(1). 14–14. 163 indexed citations
8.
Winkel, Ruud van, Marc D. Binder, D Van Eyck, et al.. (2006). Screening for Diabetes and Other Metabolic Abnormalities in Patients With Schizophrenia and Schizoaffective Disorder. The Journal of Clinical Psychiatry. 67(10). 1493–1500. 73 indexed citations
9.
Binder, Marc D., Ruud van Winkel, D Van Eyck, et al.. (2006). Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophrenia Research. 83(1). 87–93. 258 indexed citations
10.
Binder, Marc D., Ruud van Winkel, Martien Wampers, et al.. (2006). Treatment With Rosuvastatin for Severe Dyslipidemia in Patients With Schizophrenia and Schizoaffective Disorder. The Journal of Clinical Psychiatry. 67(12). 1889–1896. 55 indexed citations
11.
Binder, Marc D., et al.. (2006). Body weight and self-esteem in patients with schizophrenia evaluated with B-WISE®. Schizophrenia Research. 88(1-3). 222–226. 59 indexed citations
12.
Binder, Marc D., L. Hanssens, Ruud van Winkel, et al.. (2006). A Case Series: Evaluation of the Metabolic Safety of Aripiprazole. Schizophrenia Bulletin. 33(3). 823–830. 61 indexed citations
13.
Binder, Marc D., Ruud van Winkel, D Van Eyck, et al.. (2006). Prevalence of the Diabetes, Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia over the Course of the Illness: a Cross-Sectional Study. Drug Safety. 29(10). 911–1010. 26 indexed citations
14.
Eyck, D Van, Marc D. Binder, Martien Wampers, et al.. (2005). Oral glucose tolerance tests in schizophrenia for "dummies," making sense of potentially predictive prediabetic insulin and glucose curves. Schizophrenia Bulletin. 31(2). 572–572. 2 indexed citations
15.
Peuskens, Joseph, Marc D. Binder, D Van Eyck, et al.. (2005). Metabolic syndrome in schizophrenic patients treated with antipsychotics. Schizophrenia Bulletin. 31(2). 568–568. 1 indexed citations
16.
Binder, Marc D., D Van Eyck, Linda Hanssens, et al.. (2005). Oral glucose tolerance tests in treated patients with schizophrenia.. European Psychiatry. 21(4). 224–226. 28 indexed citations
17.
Eyck, D Van, Marc D. Binder, Hendrik Peuskens, et al.. (2004). The metabolic syndrome in schizophrenic patients treated with antipsychotics. The International Journal of Neuropsychopharmacology. 7. 1 indexed citations
18.
Binder, Marc D., Martien Wampers, D Van Eyck, & Joseph Peuskens. (2004). Somatic medication in hospitalized schizophrenic patients in Belgium. The International Journal of Neuropsychopharmacology. 7. 3 indexed citations
19.
Binder, Marc D., D Van Eyck, Hendrik Peuskens, et al.. (2004). Oral glucose tolerance tests in schizophrenic patients treated with antipsychotics. The International Journal of Neuropsychopharmacology. 7. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Mackin Breakdown of academic impact, for papers by K.G. Kahl Breakdown of academic impact, for papers by Claudia Asenjo‐Lobos Breakdown of academic impact, for papers by Tara B. Daley Breakdown of academic impact, for papers by D. Gustafson Breakdown of academic impact, for papers by Calum D. Moulton Breakdown of academic impact, for papers by Anne M. Frederickson Breakdown of academic impact, for papers by Anette Riisgaard Ribe Breakdown of academic impact, for papers by Candy W. Y. Law Breakdown of academic impact, for papers by Aisha A. Seyal
Rankless by CCL
2026